Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0BI1O
|
|||
| Drug Name |
PMID28051882-Compound-Figure9
|
|||
| Drug Type |
Small molecular drug
|
|||
| Company |
WASHINGTON UNIVERSITY
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C53H67N7O7
|
|||
| Canonical SMILES |
CCOC1=CC=CC=C1N2C(=NC3=CC=CC=C3C2=O)CN4CCN(CC4)C(=O)COC5=CC=C(C=C5)CNCCCCCCN6C7CCCC6CC(C7)OC(=O)NC8=C(C=CC(=C8)C)OC
|
|||
| InChI |
1S/C53H67N7O7/c1-4-65-49-19-10-9-18-47(49)60-50(55-45-17-8-7-16-44(45)52(60)62)36-57-28-30-58(31-29-57)51(61)37-66-42-23-21-39(22-24-42)35-54-26-11-5-6-12-27-59-40-14-13-15-41(59)34-43(33-40)67-53(63)56-46-32-38(2)20-25-48(46)64-3/h7-10,16-25,32,40-41,43,54H,4-6,11-15,26-31,33-37H2,1-3H3,(H,56,63)
|
|||
| InChIKey |
NMJRVPZKOISERX-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Sigma intracellular receptor 2 (TMEM97) | Target Info | Ligand | [1] |
| Target's Patent Info | Sigma intracellular receptor 2 (TMEM97) | Target's Patent Info | [1] | |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Are sigma modulators an effective opportunity for cancer treatment A patent overview (1996-2016).Expert Opin Ther Pat. 2017 May;27(5):565-578. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.